Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana

MLA

Ontlametse T. Bareng, et al. “Doravirine-Associated Resistance Mutations in Antiretroviral Therapy Naïve and Experienced Adults with HIV-1 Subtype C Infection in Botswana.” Journal of Global Antimicrobial Resistance, vol. 31, Dec. 2022, pp. 128–34. EBSCOhost, https://doi.org/10.1016/j.jgar.2022.08.008.

APA

Ontlametse T. Bareng, Sekgabo Seselamarumo, Kaelo K. Seatla, Wonderful T. Choga, Blessing Bakae, Dorcas Maruapula, Nametso Kelentse, Natasha O. Moraka, Baitshepi Mokaleng, Patrick T. Mokgethi, Tsotlhe R. Ditlhako, Molly Pretorius-Holme, Mpaphi B. Mbulawa, Refeletswe Lebelonyane, Ebi Celestin Bile, Tendani Gaolathe, Roger Shapiro, Joseph M. Makhema, Shahin Lockman, … Simani Gaseitsiwe. (2022). Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana. Journal of Global Antimicrobial Resistance, 31, 128–134. https://doi.org/10.1016/j.jgar.2022.08.008

Chicago

Ontlametse T. Bareng, Sekgabo Seselamarumo, Kaelo K. Seatla, Wonderful T. Choga, Blessing Bakae, Dorcas Maruapula, Nametso Kelentse, et al. 2022. “Doravirine-Associated Resistance Mutations in Antiretroviral Therapy Naïve and Experienced Adults with HIV-1 Subtype C Infection in Botswana.” Journal of Global Antimicrobial Resistance 31 (December): 128–34. doi:10.1016/j.jgar.2022.08.008.